Japan Pharma Gearing Up For Battle In Reimbursement Talks As Tax Landscape Shifts
This article was originally published in PharmAsia News
Executive Summary
Increased consumption tax and tax credits for R&D offer a new playing field as 2014 price revision talks take shape.